Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in Br J Cancer

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    July 2017
  1. LAJER CB, Garnaes E, Friis-Hansen L, Norrild B, et al
    The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer.
    Br J Cancer. 2017 Jul 13. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    May 2017
  2. BROWN TE, Banks MD, Hughes BGM, Lin CY, et al
    Randomised controlled trial of early prophylactic feeding vs standard care in patients with head and neck cancer.
    Br J Cancer. 2017 May 23. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    April 2017
  3. SUH YE, Lawler K, Henley-Smith R, Pike L, et al
    Association between hypoxic volume and underlying hypoxia-induced gene expression in oropharyngeal squamous cell carcinoma.
    Br J Cancer. 2017;116:1057-1064.
    PubMed     Text format     Abstract available


    March 2017
  4. PETRICK JL, Kelly SP, Liao LM, Freedman ND, et al
    Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies.
    Br J Cancer. 2017;116:951-959.
    PubMed     Text format     Abstract available


  5. CROSBY T, Hurt CN, Falk S, Gollins S, et al
    Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer.
    Br J Cancer. 2017;116:709-716.
    PubMed     Text format     Abstract available


    February 2017
  6. SUNDQUIST E, Kauppila JH, Veijola J, Mroueh R, et al
    Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups.
    Br J Cancer. 2017;116:640-648.
    PubMed     Text format     Abstract available


  7. HALL PS, Lord SR, Collinson M, Marshall H, et al
    A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO).
    Br J Cancer. 2017;116:472-478.
    PubMed     Text format     Abstract available


    January 2017
  8. LEFEVRE M, Rousseau A, Rayon T, Dalstein V, et al
    Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study.
    Br J Cancer. 2017;116:362-369.
    PubMed     Text format     Abstract available


  9. WELSH L, Panek R, Riddell A, Wong K, et al
    Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck.
    Br J Cancer. 2017;116:28-35.
    PubMed     Text format     Abstract available


    October 2016
  10. COOK MB, Drahos J, Wood S, Enewold L, et al
    Pathogenesis and progression of oesophageal adenocarcinoma varies by prior diagnosis of Barrett's oesophagus.
    Br J Cancer. 2016 Oct 25. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    September 2016
  11. BHIDE SA, Thway K, Lee J, Wong K, et al
    Delayed DNA double-strand break repair following platin-based chemotherapy predicts treatment response in head and neck squamous cell carcinoma.
    Br J Cancer. 2016 Sep 1. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    July 2016
  12. SRIDHARAN V, Margalit DN, Lynch SA, Severgnini M, et al
    Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer.
    Br J Cancer. 2016;115.
    PubMed     Text format     Abstract available


    March 2016
  13. ZEVALLOS JP, Mazul AL, Rodriguez N, Weissler MC, et al
    Previous tonsillectomy modifies odds of tonsil and base of tongue cancer.
    Br J Cancer. 2016;114:832-8.
    PubMed     Text format     Abstract available


  14. TEBBUTT NC, Price TJ, Ferraro DA, Wong N, et al
    Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial.
    Br J Cancer. 2016;114:505-9.
    PubMed     Text format     Abstract available


    February 2016
  15. WERNER TA, Tamkan-Olcek Y, Dizdar L, Riemer JC, et al
    Survivin and XIAP: two valuable biomarkers in medullary thyroid carcinoma.
    Br J Cancer. 2016;114:427-34.
    PubMed     Text format     Abstract available


  16. JANOWITZ T, Thuss-Patience P, Marshall A, Kang JH, et al
    Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma: a meta-analysis of patient-level data.
    Br J Cancer. 2016;114:381-7.
    PubMed     Text format     Abstract available


  17. WANG C, Guan S, Liu F, Chen X, et al
    Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma.
    Br J Cancer. 2016;114:290-7.
    PubMed     Text format     Abstract available


    December 2015
  18. BOGDANOVA TI, Zurnadzhy LY, Nikiforov YE, Leeman-Neill RJ, et al
    Histopathological features of papillary thyroid carcinomas detected during four screening examinations of a Ukrainian-American cohort.
    Br J Cancer. 2015;113:1556-64.
    PubMed     Text format     Abstract available


  19. BOSSI P, Orlandi E, Licitra L
    Comment on 'Impact of intra-arterial chemotherapy including internal carotid artery for advanced paranasal sinus cancers involving the skull base'.
    Br J Cancer. 2015;113:1638-9.
    PubMed     Text format    


    November 2015
  20. LAGARDE SM, Phillips AW, Navidi M, Disep B, et al
    The presence of lymphovascular and perineural infiltration after neoadjuvant therapy and oesophagectomy identifies patients at high risk for recurrence.
    Br J Cancer. 2015;113:1427-33.
    PubMed     Text format     Abstract available


  21. FETONI AR, Paciello F, Mezzogori D, Rolesi R, et al
    Molecular targets for anticancer redox chemotherapy and cisplatin-induced ototoxicity: the role of curcumin on pSTAT3 and Nrf-2 signalling.
    Br J Cancer. 2015;113:1434-44.
    PubMed     Text format     Abstract available


  22. DE SILVA N, Schulz L, Paterson A, Qain W, et al
    Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma.
    Br J Cancer. 2015;113:1305-12.
    PubMed     Text format     Abstract available


  23. BYRNE AM, Bekiaris S, Duggan G, Prichard D, et al
    Golgi phosphoprotein 2 (GOLPH2) is a novel bile acid-responsive modulator of oesophageal cell migration and invasion.
    Br J Cancer. 2015;113:1332-42.
    PubMed     Text format     Abstract available


    September 2015
  24. PIRO G, Giacopuzzi S, Bencivenga M, Carbone C, et al
    TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients.
    Br J Cancer. 2015;113:878-85.
    PubMed     Text format     Abstract available


  25. LIU JY, Li F, Wang LP, Chen XF, et al
    CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma.
    Br J Cancer. 2015;113:747-55.
    PubMed     Text format     Abstract available


  26. CAO W, Peters JH, Nieman D, Sharma M, et al
    Macrophage subtype predicts lymph node metastasis in oesophageal adenocarcinoma and promotes cancer cell invasion in vitro.
    Br J Cancer. 2015;113:738-46.
    PubMed     Text format     Abstract available


    August 2015
  27. OGUEJIOFOR K, Hall J, Slater C, Betts G, et al
    Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma.
    Br J Cancer. 2015 Aug 27. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  28. FEILCHENFELDT J, Varga Z, Siano M, Grabsch HI, et al
    Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2).
    Br J Cancer. 2015 Aug 27. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: